A detailed history of Steward Financial Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Steward Financial Group LLC holds 123 shares of VRTX stock, worth $57,579. This represents 0.01% of its overall portfolio holdings.

Number of Shares
123
Previous 123 -0.0%
Holding current value
$57,579
Previous $43,000 2.33%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$314.42 - $351.91 $314 - $351
-1 Reduced 0.81%
123 $43,000
Q1 2023

May 05, 2023

BUY
$283.23 - $323.1 $7,080 - $8,077
25 Added 25.25%
124 $39,000
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $28,290 - $31,826
99 New
99 $28,000
Q2 2022

Jul 22, 2022

SELL
$234.96 - $292.55 $7,753 - $9,654
-33 Reduced 25.0%
99 $27,000
Q1 2022

May 03, 2022

BUY
$221.42 - $260.97 $29,227 - $34,448
132 New
132 $34,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.